New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 19, 2014
10:17 EDTTOL, PHM, WLH, RYL, HOV, LENHomebuilders rebound after KB Home results beat expectations
Shares of homebuilders are rising in today's down market after one of the companies in the sector, KB Home (KBH), reported stronger than expected results. WHAT'S NEW: KB Home reported first quarter earnings per share of 12c, compared with analysts' consensus estimate of 8c. The company's revenue was also higher than expected. KB's homebuilding operating income jumped to $17.7M, versus $500K in the same period a year earlier. The average selling price of the company's homes jumped 12% year-over-year, and the net value of its orders rose 18%. KB's housing gross profit margin increased to 17.7%, up from 14.8% in the same period a year earlier. WHAT'S NOTABLE: KB Home's stronger than expected results come after some recent negative news for the sector. On February 25, homebuilder Toll Brothers said that its contracts for units had dropped about 8% in the first three and a half weeks of its second quarter. The company also reduced the high end of its fiscal 2014 home delivery guidance. On March 12, Credit Suisse downgraded its rating on Toll Brothers (TOL), along with peers Pulte Group (PHM) and William Lyon Homes (WLH). The spring selling season looks set to be "underwhelming," the firm warned. PRICE ACTION: In early trading, Lennar rose 4% to $42.20, Ryland (RYL) advanced 2.8% to $42.55, Hovnanian (HOV) added 3% to $5.10, PulteGroup gained 3% to $20.05, William Lyon added 1.5% to $29.80, and KB Home rose 9% to $19.25.
News For LEN;RYL;PHM;HOV;WLH;TOL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 18, 2014
09:24 EDTWLHWilliam Lyon Homes upgraded to Outperform from Neutral at Credit Suisse
Subscribe for More Information
06:10 EDTWLHWilliam Lyon Homes announces pricing of tangible equity units
Subscribe for More Information
November 17, 2014
16:24 EDTWLHOn The Fly: Closing Wrap
Stocks on Wall Street were quiet and traded in a fairly narrow range for their sixth straight session, despite a "merger Monday" that saw over $100B in deals announced. The Dow and S&P, which began the week near record levels, passed back and forth across the flat line several times during the day, though the Nasdaq weakened early in the session and never really recovered. ECONOMIC EVENTS: In the U.S., industrial production fell 0.1% in October, missing expectations for it to have risen 0.2% from the prior month. October capacity utilization came in at 78.9%, which fell short of the expected 79.3% rate. The Empire State manufacturing index, which reflects manufacturing activity in the New York region, rose 4 points to 10.2 in November, which was generally in-line with the consensus forecast. In Asia, Japan's GDP unexpectedly shrank an annualized 1.6% last quarter, missing projections for a 2.2% gain and sinking its economy into a recession. COMPANY NEWS: Actavis (ACT) gained $4.17, or 1.71%, to $247.94 after confirming that it agreed to acquire Allergan (AGN) for a combination of $129.22 in cash and 0.3683 Actavis shares valued at approximately $66B, or $219 per Allergan share. Valeant Pharmaceuticals (VRX), which had been in a contentious fight to buy Allergan, commented that it "cannot justify to its own shareholders" paying a price of $219 or more per share for the Botox maker, whose stock rose $10.55, or 5.31%, to $209.20... Halliburton (HAL), conversely, fell $5.85, or 10.62%, to $49.23 after it agreed to acquire Baker Hughes (BHI) in a stock and cash transaction valued at $78.62 per Baker Hughes share, representing an enterprise value of $38B. When the deal talks were first reported by The Wall Street Journal last week, antitrust concerns were highlighted by analysts, but Halliburton said it had agreed to divest businesses that generate up to $7.5B in revenues, if required by regulators, and agreed to pay a fee of $3.5B if the transaction terminates due to a failure to obtain required approvals. Baker Hughes rose $5.34, or 8.92%, to $65.23 after the deal was announced. MAJOR MOVERS: Among the notable gainers was Celldex Therapeutics (CLDX), which advanced $4.09, or 28.88%, to $18.25 after the company reported it saw a statistically significant overall survival benefit, along with an increase in clinically meaningful tumor shrinkage, in a sub-group of its study of a drug to treat a specific type of brain tumor. Also higher was Amicus Therapeutics (FOLD), which rose $1.01, or 17.75%, to $6.70 after the company announced additional data on secondary endpoints from its second Phase 3 study of its treatment for Fabry disease. Among the noteworthy losers was William Lyon Homes (WLH), which fell $3.52, or 15.53%, to $19.14 after the company announced that it intends to offer, subject to market and other conditions, 1M tangible equity units, which will consist of a prepaid stock purchase contract and an amortizing note. Also lower were shares of DreamWorks (DWA), which dropped $3.71, or 14.26%, to $22.31 after multiple media outlets reported that talks about a takeover of the company by Hasbro (HAS) had ended. INDEXES: The Dow gained 13.01, or 0.07%, to 17,647.75, the Nasdaq lost 17.54, or 0.37%, to 4,671.00, and the S&P 500 added 1.50, or 0.07%, to 2,041.32.
07:35 EDTWLHWilliam Lyon Homes files to sell tangible equity units
Subscribe for More Information
November 13, 2014
07:18 EDTTOL, HOV, RYL, PHM, LENUBS to hold a conference
Building & Building Products Annual CEO Conference is being held in New York on November 13 with webcasted company presentations to begin at 9:30 am; not all company presentations may be webcasted. Webcast Link
November 10, 2014
10:04 EDTPHMOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:51 EDTPHMPulteGroup upgraded at BofA/Merrill
As previously reported, BofA/Merrill upgraded PulteGroup to Buy from Neutral. The firm's checks indicate PulteGroup's order growth is at a positive inflection point and its balanced approach to capital allocation will drive EPS accretion. Price target raised to $25 from $23.
07:10 EDTTOLToll Brothers reports preliminary Q4 revenue $1.35B, consensus $1.31B
Toll Brothers Q4 total revenues of $1.35B and 1,807 units increased 29% in dollars and 22% in units, compared to 4Q13 results of $1.04B and 1,485 units. The average price of homes delivered was $747,000, compared to $732,000 in Q3 and $703,000 in 4Q13. net signed contracts of $970.2M and 1,282 units rose 16% in dollars and 10% in units, compared to FY 2013's fourth-quarter net signed contracts of $839.0M and 1,163 units. The average price per unit of net contracts signed in Q4 was $757,000, compared to $717,000 in Q3 and $721,000 in 4Q13. On a per-community basis, Q4 net signed contracts were 5.01, compared to 4Q13 totals of 5.17, 4.86 in 4Q12, 3.04 in 4Q11 and 2.94 in 4Q10.
06:09 EDTPHMPulteGroup upgraded to Buy from Neutral at BofA/Merrill
Subscribe for More Information
November 7, 2014
12:10 EDTPHMStocks with call strike movement; NVDA PHM
Subscribe for More Information
08:34 EDTWLHWilliam Lyon Homes reports Q3 pro forma homebuilding revenue $230M
Subscribe for More Information
08:32 EDTWLHWilliam Lyon Homes reports Q3 ASP of new homes delivered $462,500
Reports Q3 homebuilding gross margin percentage of 19.6%. Reports Q3 net new home orders of 422, up 35%. Reports Q3 home sales revenue of $196.1M up 39%
08:31 EDTWLHWilliam Lyon Homes reports Q3 EPS ex-items 31c, consensus 27c
Reports Q3 consolidated revenue $206.9M, consensus $241.32M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use